FDA Extends Review of Amgen’s Lumakras for KRAS G12C mCRC Treatment to January 2025
On October 18, FirstWord reported that the U.S. FDA has extended the review period for...
Fineline Cube
Shenzhen Chipscreen Advances CS231295 for Cancer Treatment as IND Accepted by NMPA
On October 17, Shenzhen Chipscreen Biosciences Co., Ltd. (SHA: 688321) announced that its innovative Class...
Pfizer Partners with TRIANA Biomedicines to Develop Molecular Glue Degraders for Oncology and Other Diseases
Pfizer (NSE: PFIZER), a leading US pharmaceutical company, has entered into a strategic partnership and...
AstraZeneca Files for Market Approval of Tremelimumab in China for Hepatocellular Carcinoma
The Center for Drug Evaluation (CDE) has indicated on its website that AstraZeneca (NASDAQ: AZN),...
MicroPort CardioFlow’s Heart Valve Balloon Dilatation Catheter Alwide Plus Gains Mexican Approval
MicroPort Scientific Corp., a leading Chinese medical device company (HKG: 0853), through its spin-off MicroPort...
Changshan Biochemical Pharmaceutical Wins Marketing Approval for Enoxaparin in Niger
Hebei Changshan Biochemical Pharmaceutical Co., Ltd (CSBIO; SHE: 300255), a Chinese pharmaceutical company, has announced...
Huahai Pharmaceutical Gets FDA Nod for Generic Empagliflozin and Metformin ANDA
Zhejiang Huahai Pharmaceutical Co., Ltd (SHA: 600521), a prominent Chinese pharmaceutical company, has announced the...
Laekna Advances Obesity Treatment Candidate LAE102 with Subcutaneous Dosing in Phase I Study
Laekna, a Sino-US biotech firm, has announced the commencement of a subcutaneous dosing cohort within...
Sanofi Invests EUR 300 Million in Joint Venture with Orano Med for Next-Generation Radioligand Therapies
Sanofi (EPA: SAN), a leading French pharmaceutical company, has entered into a strategic agreement with...
Antengene’s Xpovio Secures Expanded Access in South Korea for Multiple Myeloma Treatment
Antengene Corp., Ltd (HKG: 6996), a China-based biopharmaceutical company, has announced that it has received...
AbbVie’s Vyalev Wins FDA Approval as First Subcutaneous Levodopa Therapy for Advanced Parkinson’s
AbbVie (NYSE: ABBV), a leading pharmaceutical company based in the US, has received approval from...
Chengdu Drafts Comprehensive Policy to Stimulate Biomedical Industry Growth
The Chengdu Municipal Bureau of Economic and Information Technology has unveiled a draft proposal titled...
Chongqing Zhifei Biological’s EC Injection Receives Market Approval in Indonesia
Chongqing Zhifei Biological Co., Ltd (SHE: 300122), a leading biopharmaceutical company based in China, has...
Tencent Invests USD 30 Million in Early Cancer Detection Firm Insighta, Backed by Prenetics
Prenetics Global Limited (NASDAQ: PRE), a prominent health sciences company with operations in the US...
LaNova Medicines Secures RMB 300 Million in Series C1 Financing to Advance Cancer Therapy Pipeline
LaNova Medicines Ltd, a Shanghai-based developer of cancer therapies, has announced the successful completion of...
Abbott Laboratories Posts 9.4% Q3 Sales Growth, Driven by Medical Devices and Pharmaceuticals
Abbott Laboratories (NYSE: ABT), a U.S.-based healthcare giant, has reported its financial results for the...
Chengdu Baiyu Pharmaceutical Strikes Licensing Deal with Novartis for Unannounced Anti-Tumor Asset
Chengdu Baiyu Pharmaceutical Co., Ltd., a Chinese pharmaceutical company, has entered into a licensing agreement...
Cryofocus Medtech Partners with Guangzhou Medical University Hospital for Cryoballoon Ablation R&D
Cryofocus Medtech (Shanghai) Co., Ltd. (HKG: 6922), a Shanghai-based leader in cryoablation treatment, and the...
Kintor Pharmaceutical Initiates Phase II/III Trial for KX-826 Tincture 1.0% in Treating Male Androgenetic Alopecia
Kintor Pharmaceutical Ltd (HKG: 9939), a biopharmaceutical company based in China, has announced the commencement...
Novocure’s Optune Lua Wins FDA Approval for mNSCLC Treatment in Combination with Immunotherapies
Novocure (NASDAQ: NVCR), a Swiss firm renowned for its pioneering Tumor Treating Fields (TTFields) cancer...